Skip to main content
. Author manuscript; available in PMC: 2009 Sep 1.
Published in final edited form as: Allergy. 2008 Sep;63(9):1156–1163. doi: 10.1111/j.1398-9995.2008.01709.x

Figure 5.

Figure 5

Siglec-F antibody treatment leads to eosinophil apoptosis in vitro. Eosinophils (derived from IL-5 transgenic mice) were incubated with rat anti-Siglec-F or CD44 for 4 or 24 h and apoptosis determined by flow cytometry (CCR3+ Annexin-V+). Data are mean ± SD of 3–4 experiments. *P < 0.05 for Siglec-F vs CD44 and P < 0.02 for Siglec-F vs no antibody (paired t-test).